Fast, Assured Delivery

Continued Unrivaled Performance 

Clinician-friendly improvements sustain aerosol output and enhance breath actuation while continuing to deliver high, effective respirable dose with faster treatment times. 

Less Clinician Drug Exposure

The AeroEclipse® II BAN creates aerosol in precise response to the patient's inspiratory maneuver.  This patient on-demand therapy means less medication waste, higher drug delivery efficiency and safer clinician working environments.

For All Your Patients

The AeroEclipse® II BAN is designed to meet your patients needs throughout the hospital.  You can use the AeroEclipse® II BAN - with a mouthpiece or our latex-free masks - from the Emergency Department to the floors, from young to adult patients.

This study used the AeroEclipse® Breath Actuated Nebulizer (BAN), not the AeroEclipse® II Breath Actuate Nebulizer which is currently on the market.  The AeroEclipse® BAN and the AeroEclipse® II BAN are equivalent in regards to in vitro performance.*

*ARE FIRST AND SECOND GENERATION, MECHANICALLY-OPERATED BREATH-ACTUATED NEBULIZERS (BAN) COMPARABLE BASED ON IN VITRO PERFORMANCE?
J. Schmidt, J. Pevler, C. Doyle, K. Wiersema, M. Nagel, J. Mitchell; Respiratory Drug Delivery, 2006: 817-819.

Of course it's from Monaghan™.